Dr. Charles Cantor is one of the pioneers of the Human Genome Project, Chairman of Sequenom, Inc.’s Scientific Advisory Board, and was appointed Chief Scientific Officer in June 1998. Dr. Cantor was previously the chair and professor of the department of biomedical engineering and biophysics, and director of the Center for Advanced Biotechnology at Boston University. Prior to this Dr. Cantor was chairman at Columbia University College of Physicians & Surgeons, and Professor of Molecular Biology, University of California, Berkeley. He was also director of the Human Genome Center Project of the Department of Energy at Lawrence Berkeley Laboratory. Dr. Cantor is a consultant to more than 16 biotech firms, has published over 400 peer reviewed articles, authored and co-authored over 50 US and international patents, and co-authored a three-volume textbook on biophysical chemistry. He is also an author of the first genomics textbook, Genomics: The Science and Technology of the Human Genome Project.